Aller au contenu
Aspivix logo
  • Nouvelles
  • A propos de nous
  • Contact
  • Français
    • English
    • Italiano
    • Deutsch
Search
Close
  • Pour les professionnels de la santé
  • Pour les femmes
  • Ressources
Commander
  • Nouvelles
  • A propos de nous
  • Contact
  • Français
    • English
    • Italiano
    • Deutsch
Restez informé(e)
  • Pour les professionnels de la santé
  • Pour les femmes
  • Ressources
Aspivix logo
Home > Nouvelles

Contact Presse
Pour une demande de relations médias, écrivez à l'adresse :contact@aspivix.com

Tous
  • Tous
  • Blog
  • Communiqués de presse
  • Dans les médias
More than 40% of Pregnancies Globally are Unintended

Plus de 40 % des grossesses dans le monde sont involontaires

juin 20, 2020
Dans le monde, environ 85 millions de grossesses annuelles ne sont pas planifiées, soit plus de 40 % de l'ensemble des grossesses. Ces grossesses donnent lieu à 50% d'avortements, 12% de fausses...
En savoir plus about Plus de 40 % des grossesses dans le monde sont involontaires
Replacing a Centuries-Old Gynecological Instrument

Remplacer un instrument gynécologique vieux de plusieurs siècles

décembre 8, 2019
En savoir plus about Remplacer un instrument gynécologique vieux de plusieurs siècles
88

ASPIVIX en finale du Venture Kick

novembre 11, 2019
En savoir plus about ASPIVIX en finale du Venture Kick
89

ASPIVIX sur la voie de la croissance

octobre 2, 2019
En savoir plus about ASPIVIX sur la voie de la croissance
Aspivix won at Startup Champions Seed Night

ASPIVIX a gagné à la Startup Champions Seed Night 2018

mars 5, 2019
En savoir plus about ASPIVIX a gagné à la Startup Champions Seed Night 2018
Aspivix among Venture Leaders Life Sciences

ASPIVIX parmi les Venture Leaders Life Sciences 2018

mai 5, 2018
En savoir plus about ASPIVIX parmi les Venture Leaders Life Sciences 2018
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Loading... loader

Entreprise

Accueil
Produits
Ressources
Carrières
Blog

Contact

Siège mondial
Aspivix SA
Route de la Corniche 8
1066 Epalinges
Suisse

Politique de confidentialité

Conditions générales

Avis de non-responsabilité : Carevix® est actuellement autorisé par la FDA pour le marché américain, marqué CE pour le marché européen et autorisé au Royaume-Uni. Disponible pour la commercialisation. Carevix® n'a pas fait l'objet d'une licence ou d'une autorisation de vente sur d'autres marchés.

© 2025 Aspivix SA. Tous droits réservés. Aspivix™ et Carevix® sont des marques commerciales ou des marques déposées d'Aspivix SA et/ou de ses filiales.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}